Your browser is no longer supported. Please, upgrade your browser.
Index- P/E- EPS (ttm)- Insider Own16.16% Shs Outstand10.64M Perf Week-7.68%
Market Cap93.30M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float5.67M Perf Month25.46%
Income- PEG- EPS next Q- Inst Own36.24% Short Float6.09% Perf Quarter-6.80%
Sales26.56M P/S3.51 EPS this Y- Inst Trans- Short Ratio6.61 Perf Half Y-
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year-
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range3.16 - 12.71 Perf YTD20.97%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-31.00% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low177.53% ATR0.60
Employees75 Current Ratio- Sales Q/Q-11.40% Oper. Margin- RSI (14)58.22 Volatility6.00% 7.81%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.59 Prev Close8.92
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume52.32K Price8.77
Recom- SMA206.18% SMA5017.69% SMA2007.31% Volume30,664 Change-1.68%
Feb-24-21Initiated SVB Leerink Outperform $20
Feb-16-21 01:28PM  
Feb-08-21 08:00AM  
Feb-01-21 07:00AM  
Jan-03-21 03:58AM  
Nov-23-20 08:00AM  
Nov-11-20 04:01PM  
Nov-09-20 04:01PM  
Nov-02-20 08:00AM  
LENSAR, Inc. operates as a commercial-stage medical device company. It focuses on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. The company was incorporated in 2004 and is headquartered in Orlando, Florida.